This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36

2026-07-23 10:03:27 (13 day(s) ago)

Summary

Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and 40…

Read full MHRA article

Respond to this alert